Invention Grant
- Patent Title: Pharmaceutical compositions
-
Application No.: US16628101Application Date: 2018-07-10
-
Publication No.: US11376223B2Publication Date: 2022-07-05
- Inventor: Matthew Carl Allgeier , Tony Yantao Zhang
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Macharri R. Vorndran-Jones
- International Application: PCT/US2018/041378 WO 20180710
- International Announcement: WO2019/018155 WO 20190124
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/24 ; A61K9/00 ; A61K31/155 ; A61K31/40 ; A61K31/41
Abstract:
The present invention relates to solid oral fixed dose compositions of metformin, atorvastatin, and valsartan, or their pharmaceutically acceptable salts, processes for the preparation thereof, and the use of the composition to treat certain diseases.
Public/Granted literature
- US20210137842A1 PHARMACEUTICAL COMPOSITIONS Public/Granted day:2021-05-13
Information query
